Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » IsoPlexis Raises Additional $20M as Part of Series C Round

IsoPlexis Raises Additional $20M as Part of Series C Round

Jan 09, 2020
|
staff reporter

NEW YORK – IsoPlexis said today that it has raised an additional $20 million as part of its Series C financing.

That follows the $25 million the company announced in May 2019, bringing the total figure for the round to $45 million. The round was led by Northpond Ventures, along with participation from existing investors.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Genomics to Trace, Prevent

Nature News reports that genomics is being applied to trace and try to prevent additional COVID-19 waves.

Sense of Scope in San Diego

Rady's Children Hospital and San Diego County are teaming up to test pediatric patients and their families for COVID-19 to gauge the spread of the virus locally, according to the San Diego Union-Tribune.

Boost to Wolf Diversity

Wildlife managers aim to boost the genetic diversity of Mexican gray wolves by placing captive-born foster pups into packs with similarly aged wild pups, the Mercury News reports.

Science Papers Present Algorithm to Diagnose Slowly Progressing Diseases, Korean Genome Project

In Science this week: Genetic Probability tool identifies likely diagnoses in 45 percent of inflammatory arthritis cases, and more.

What's Popular?

In Business News

  1. Progenity Files for IPO, Seeks to Raise up to $100M

  2. New Products Posted to GenomeWeb: Qiagen Thermo Fisher Scientific, Bruker, More

  3. BTIG Initiates Coverage of Fulgent Genetics

  4. Tangen Biosciences, LabWare Partner on Point-of-Care Coronavirus Kit

  5. Illumina, Genomic Medicine Sweden to Evaluate Sequencing-Based Leukemia Diagnostics

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.